A Phase 3 interventional study of test toothpaste and Control toothpaste in Dentin Hypersensitivity, sponsored by Colgate Palmolive. Completed at 1 site in China. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-19.
Sponsored by Colgate Palmolive · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Dentin Sensitivity with a site in China — 1 open to participants now, 1 under way, none of them phase 3. Dentin Sensitivity · China.
Among the 13 studies in Dentin Sensitivity with a site in China, this one is the 9th largest by enrollment of the 12 interventional ones that give a count, is one of 2 that started in 2025, is one of 2 in phase 3, and was the 10th registered.
291 studies on the registry are indexed under Dentin Sensitivity; 49 are open to participants now.
Browse Dentin Sensitivity studies →1 of the 13 studies in Dentin Sensitivity with a site in China is open now. Recruiting first, the newest first:
The University of Hong Kong · Sites in China
Ages 65–100 · Healthy volunteers
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 20 Dentin Sensitivity studies recruiting now, 6 (30%) set no upper age limit and 13 (65%) stop at 75 or younger; 2 take children under 18; 12 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 2 started in 2025.
This study's enrollment of 80 is above the median of 60 across 282 interventional studies indexed under Dentin Sensitivity.
Median enrollment 128 across the 12 interventional studies, 30 across the 1 observational. Of the 12 that completed or were terminated, 6 (50%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 13 have an industry lead sponsor. The 7 most frequent:
Colgate Palmolive is the lead sponsor of 120 studies on the registry; 14 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 2 (6%) have results posted.
Colgate Palmolive has 7 studies filed under Dentin Sensitivity — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Dentin Sensitivity with a site in China, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Assess the clinical efficacy of 5% Potassium Nitrate Toothpaste (Colgate-Palmolive Company, New York, NY, USA) on providing dentinal hypersensitivity relief (tactile and air blast) in comparison to Colgate Cavity Protection Toothpaste (Colgate-Palmolive Company, New York, NY, USA) over an eight-week period
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subjects will be instructed to brush their teeth with their assigned test dentifrice and toothbrush twice daily
Drug: test toothpaste
Subjects will be instructed to brush their teeth with their assigned test dentifrice and toothbrush twice daily
Drug: Control toothpaste
A commercially available fluoride toothpaste
A commercially available fluoride toothpaste
tactile sensitivity
tactile stimulation is measured by the Yeaple Electronic Force Sensing Probe
Time frame: baseline and 4 weeks, 8 week measurement
air blast sensitivity
air blast sensitivity is delivered by a standard dental unit syringe at a measured temperature of 19-21°C (70°F \[± 3°F\]) \[sensitivity will be defined by a score of 2 or 3 on the Schiff Cold Air sensitivity scale Air Sensitivity Scale
Time frame: baseline and 4 weeks, 8 week measurement
Ran from May 2025 to primary completion in Aug 2025, 3 months.
Of 13 phase 3 interventional studies under Dentin Sensitivity, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 14. This study's 3 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.